Stocks › AMRI
AMRI
AMRI·USD
—
No end-of-day price on record
AMRI
AMRI
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
AMRIS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of AMRI by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Ed WhitfieldHouse · R · KY |
AMRIAMRI · Stock |
Purchase $1,001 - $15,000 |
Sep 15, 2015 | Aug 4, 2015 | Filing ↗ |
Whale Activity
Institutional 13F positions
No 13F positions in AMRI among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by AMRI insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
597 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| FINE MARGALITExecutive Vice President, API | Disposition to issuer | −23.5K | $21.75 | $512K | Aug 31, 2017 | Form 4 ↗ |
| FINE MARGALITExecutive Vice President, API | Grant / award | +2,318 | $0.00 | $0 | Aug 31, 2017 | Form 4 ↗ |
| FINE MARGALITExecutive Vice President, API | Grant / award | +10.0K | $0.00 | $0 | Aug 31, 2017 | Form 4 ↗ |
| Ladin Felicia ISVP, Treasurer & CFO | Disposition to issuer | −63.6K | $21.75 | $1.4M | Aug 31, 2017 | Form 4 ↗ |
| Ladin Felicia ISVP, Treasurer & CFO | Grant / award | +4,993 | $0.00 | $0 | Aug 31, 2017 | Form 4 ↗ |
| Hagen Steven RSVP Manufacturing & Pharmaceut | Disposition to issuer | −43.7K | $21.75 | $949K | Aug 31, 2017 | Form 4 ↗ |
| Hagen Steven RSVP Manufacturing & Pharmaceut | Grant / award | +3,138 | $0.00 | $0 | Aug 31, 2017 | Form 4 ↗ |
| OCONNOR KEVINDirector | Disposition to issuer | −58.3K | $21.75 | $1.3M | Aug 31, 2017 | Form 4 ↗ |
| NAPOLITANO FERNANDODirector | Disposition to issuer | −3,802 | $21.75 | $83K | Aug 31, 2017 | Form 4 ↗ |
| Deming David HDirector | Disposition to issuer | −6,838 | $21.75 | $149K | Aug 31, 2017 | Form 4 ↗ |
| Gutierrez Fuentes Luis GerardoDirector | Disposition to issuer | −2.2M | $21.75 | $47.9M | Aug 31, 2017 | Form 4 ↗ |
| Gutierrez Fuentes Luis GerardoDirector | Disposition to issuer | −6,656 | $21.75 | $145K | Aug 31, 2017 | Form 4 ↗ |
| HAGEN KENNETH PAULDirector | Disposition to issuer | −6,838 | $21.75 | $149K | Aug 31, 2017 | Form 4 ↗ |
| MADDALUNA ANTHONY JDirector | Disposition to issuer | −11.2K | $21.75 | $244K | Aug 31, 2017 | Form 4 ↗ |
| D AMBRA THOMAS EDirector | Disposition to issuer | −2.4M | $21.75 | $52.1M | Aug 31, 2017 | Form 4 ↗ |
| CONWAY CHRISTOPHER M.SVP, Discovery and Development | Disposition to issuer | −47.5K | $21.75 | $1.0M | Aug 31, 2017 | Form 4 ↗ |
| CONWAY CHRISTOPHER M.SVP, Discovery and Development | Grant / award | +2,247 | $0.00 | $0 | Aug 31, 2017 | Form 4 ↗ |
| Svokos GeorgeChief Operating Officer | Disposition to issuer | −129.2K | $21.75 | $2.8M | Aug 31, 2017 | Form 4 ↗ |
| Svokos GeorgeChief Operating Officer | Grant / award | +6,064 | $0.00 | $0 | Aug 31, 2017 | Form 4 ↗ |
| BOYER MILTONSVP, Drug Product Manufacturin | Disposition to issuer | −42.1K | $21.75 | $916K | Aug 31, 2017 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding AMRI · SEC Form N-PORT
Funds report their holdings by CUSIP, and AMRI could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming AMRI as client
No lobbying filings found naming AMRI as the client.
Government Contracts
Federal awards to AMRI · USAspending
No federal contract awards found for AMRI.
U.S. Patents
Recent USPTO applications naming AMRI
No USPTO patent applications found for AMRI.
Annual Financials
From AMRI's 10-K filings · XBRL
No annual XBRL figures on record for AMRI. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 2-for-1Stock splitAug 25, 2000
- 2-for-1Stock splitAug 24, 2000
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About AMRI
From SEC EDGAR company records
No company profile on record.